Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Many is a digital health company focused on improving the management of chronic cardiovascular and metabolic conditions through automated, data-driven interventions. The company's platform integrates with existing clinical workflows to provide remote patient monitoring and personalized treatment adjustments, specifically targeting hypertension and chronic kidney disease. By leveraging behavioral science and real-time data, Many aims to reduce the burden on healthcare providers while improving patient adherence and clinical outcomes. Their services are designed to scale specialized care to large patient populations who traditionally lack access to frequent clinical touchpoints.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Many.